In a patient with acute decompensated heart failure, which is the most common inotropic agent used in acute care settings?

Explanation

## Most Common Inotropic Agent in Acute Heart Failure **Key Point:** Dobutamine is the most widely used inotropic agent in acute decompensated heart failure across most healthcare systems, including India. ### Pharmacology of Dobutamine **Mechanism of Action:** - β₁-adrenergic agonist (primary effect) - Mild β₂-adrenergic activity - Negligible α-adrenergic effect at therapeutic doses **Hemodynamic Effects:** 1. Increased contractility (positive inotrope) 2. Increased heart rate (chronotropic effect) 3. Mild peripheral vasodilation 4. Improved cardiac output and coronary perfusion ### Comparison of Inotropic Agents in Acute Heart Failure | Agent | Mechanism | Onset | Advantages | Disadvantages | |---|---|---|---|---| | **Dobutamine** | β₁ agonist | 1–2 min | Rapid onset, potent inotrope, widely available, cost-effective | Tachycardia, arrhythmias, tolerance | | Milrinone | PDE-3 inhibitor | 5–10 min | Positive inotrope + vasodilator, no tachycardia | Hypotension, systemic vasodilation, expensive | | Levosimendan | Calcium sensitizer | 10–20 min | Improves contractility without increasing O₂ demand | Not available in many countries (including India/US) | | Dopamine (low) | DA agonist | 2–5 min | Renal vasodilation at low doses | Limited inotropic effect, dose-dependent effects | **High-Yield:** Dobutamine is the **first-line inotropic agent** in acute decompensated heart failure in most Indian hospitals and NEET PG guidelines because of: - Rapid onset of action - Potent positive inotropic effect - Availability and cost-effectiveness - Established safety profile **Clinical Pearl:** Dobutamine is typically used as a **short-term bridge** (hours to days) in acute settings. Prolonged use (>72 hours) is associated with tachyphylaxis and increased mortality. In chronic heart failure, inotropic support is generally avoided unless as a bridge to transplantation. **Warning:** Dobutamine can cause **tachycardia and arrhythmias**, especially in ischemic heart disease. It should be used cautiously in patients with acute coronary syndrome.